drugset / Trial / NCT00545935

Safety and Efficacy of Methylene Blue Combined With Amodiaquine or Artesunate for Malaria Treatment in Children of Burkina Faso

NCT00545935

Phase 2 Completed 186 enrolled Heidelberg University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to investigate the safety and efficacy profile of a new paediatric MB formulation combined with AQ or AS and compared to AS-AQ in young African children with uncomplicated falciparum malaria.

Timeline

Start
2007-07
Primary completion
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Artesunate Small molecule 4 mg/kg
Comparator Methylenblue Unknown 10 mg/kg
Comparator amodiaquine Other / unclassified 10 mg/kg

Indications